The CRO preclinical services market is dominated by North America, and is expected to reach $13.2 billion by 2020. According to a recent study, the biopharmaceutical industry contributed 4% of US GDP in 2015. Increasing outsourcing activities by government and academic institutes are likely to spur growth of this market. Government and academic institutes have also become the largest source of CRO revenue, and are expected to continue their dominance during the forecast period.
The global preclinical CRO
